Proficiency testing results for catecholamines
| Variable | Year | Trial | Specimen no. | No. | Median | Minimum | Maximum |
|---|---|---|---|---|---|---|---|
| Catecholamines, plasma (pg/mL) | |||||||
| Dopamine | 2018 | 1st | CMCP-18-01 | 6 | 390.0 | 311.0 | 455.0 |
| CMCP-18-02 | 80.0 | 53.0 | 166.0 | ||||
| CMCP-18-03 | 220.0 | 190.0 | 391.0 | ||||
| 2nd | CMCP-18-04 | 5 | 79.00 | 78.50 | 132.60 | ||
| CMCP-18-05 | 394.20 | 341.00 | 485.50 | ||||
| CMCP-18-06 | 29.80 | 0.00 | 64.20 | ||||
| 2019 | 1st | CMCP-19-01 | 6 | 320.2 | 306.2 | 540.4 | |
| CMCP-19-02 | 177.7 | 135.5 | 317.0 | ||||
| CMCP-19-03 | 65.6 | 23.5 | 95.6 | ||||
| 2nd | CMCP-19-04 | 5 | 673.9 | 478.8 | 700.0 | ||
| CMCP-19-05 | 832.8 | 693.5 | 977.2 | ||||
| CMCP-19-06 | 347.0 | 227.3 | 365.8 | ||||
| Epinephrine | 2018 | 1st | CMCP-18-01 | 6 | 1040.0 | 965.0 | 1337.0 |
| CMCP-18-02 | 66.0 | 62.0 | 93.0 | ||||
| CMCP-18-03 | 536.0 | 515.0 | 756.0 | ||||
| 2nd | CMCP-18-04 | 6 | 94.0 | 67.0 | 114.7 | ||
| CMCP-18-05 | 1389.7 | 969.0 | 1537.5 | ||||
| CMCP-18-06 | 24.8 | 0.0 | 56.0 | ||||
| 2019 | 1st | CMCP-19-01 | 7 | 1099.0 | 893.2 | 1462.0 | |
| CMCP-19-02 | 587.4 | 414.3 | 836.2 | ||||
| CMCP-19-03 | 81.1 | 57.7 | 118.7 | ||||
| 2nd | CMCP-19-04 | 6 | 373.0 | 284.7 | 383.0 | ||
| CMCP-19-05 | 600.0 | 527.3 | 645.0 | ||||
| CMCP-19-06 | 116.4 | 72.4 | 131.1 | ||||
| Norepinephrine | 2018 | 1st | CMCP-18-01 | 6 | 1253.0 | 1215.0 | 1493.0 |
| CMCP-18-02 | 281.0 | 249.0 | 311.0 | ||||
| CMCP-18-03 | 788.0 | 688.0 | 859.0 | ||||
| 2nd | CMCP-18-04 | 6 | 317.5 | 280.0 | 349.0 | ||
| CMCP-18-05 | 1312.4 | 1156.0 | 1488.1 | ||||
| CMCP-18-06 | 28.0 | 0.0 | 37.0 | ||||
| 2019 | 1st | CMCP-19-01 | 7 | 1223.8 | 1152.1 | 1541.6 | |
| CMCP-19-02 | 744.3 | 618.0 | 1013.0 | ||||
| CMCP-19-03 | 283.4 | 248.8 | 395.4 | ||||
| 2nd | CMCP-19-04 | 6 | 1151.2 | 1063.3 | 1253.0 | ||
| CMCP-19-05 | 2028.3 | 1785.3 | 2134.0 | ||||
| CMCP-19-06 | 302.4 | 279.5 | 316.7 | ||||
| Catecholamines, urine (ng/mL) | |||||||
| Dopamine | 2018 | 1st | CMU-18-01 | 8 | 79.0 | 72.0 | 189.0 |
| CMU-18-02 | 80.0 | 77.0 | 143.0 | ||||
| CMU-18-03 | 487.0 | 363.0 | 565.0 | ||||
| 2nd | CMU-18-04 | 6 | 70.7 | 60.5 | 77.7 | ||
| CMU-18-05 | 414.6 | 350.6 | 511.8 | ||||
| CMU-18-06 | 700.1 | 658.6 | 784.6 | ||||
| 2019 | 1st | CMU-19-01 | 7 | 716.6 | 672.9 | 816.8 | |
| CMU-19-02 | 416.5 | 370.8 | 441.4 | ||||
| CMU-19-03 | 73.0 | 63.1 | 90.9 | ||||
| 2nd | CMU-19-04 | 6 | 405.4 | 383.9 | 422.0 | ||
| CMU-19-05 | 73.8 | 62.9 | 79.2 | ||||
| CMU-19-06 | 708.6 | 613.9 | 769.3 | ||||
| Epinephrine | 2018 | 1st | CMU-18-01 | 8 | 14.0 | 13.0 | 28.0 |
| CMU-18-02 | 14.0 | 12.0 | 24.0 | ||||
| CMU-18-03 | 82.0 | 69.0 | 98.0 | ||||
| 2nd | CMU-18-04 | 6 | 12.0 | 10.5 | 13.7 | ||
| CMU-18-05 | 77.9 | 62.5 | 86.5 | ||||
| CMU-18-06 | 130.7 | 105.1 | 141.4 | ||||
| 2019 | 1st | CMU-19-01 | 7 | 110.3 | 89.8 | 132.6 | |
| CMU-19-02 | 69.9 | 57.3 | 75.5 | ||||
| CMU-19-03 | 13.6 | 10.5 | 14.5 | ||||
| 2nd | CMU-19-04 | 6 | 64.0 | 60.7 | 71.6 | ||
| CMU-19-05 | 12.3 | 10.9 | 14.0 | ||||
| CMU-19-06 | 111.8 | 92.8 | 125.4 | ||||
| Norepinephrine | 2018 | 1st | CMU-18-01 | 8 | 45.0 | 42.0 | 76.0 |
| CMU-18-02 | 45.0 | 42.0 | 112.0 | ||||
| CMU-18-03 | 202.0 | 175.0 | 216.0 | ||||
| 2nd | CMU-18-04 | 6 | 40.4 | 36.8 | 43.2 | ||
| CMU-18-05 | 182.7 | 167.1 | 200.6 | ||||
| CMU-18-06 | 294.1 | 284.3 | 329.9 | ||||
| 2019 | 1st | CMU-19-01 | 7 | 299.8 | 266.6 | 325.1 | |
| CMU-19-02 | 166.5 | 156.8 | 180.5 | ||||
| CMU-19-03 | 41.5 | 36.7 | 45.0 | ||||
| 2nd | CMU-19-04 | 6 | 166.7 | 159.5 | 170.9 | ||
| CMU-19-05 | 41.6 | 39.2 | 45.3 | ||||
| CMU-19-06 | 296.5 | 280.4 | 326.9 | ||||
없음